D.E. Shaw & Co’s Lexicon Pharmaceuticals LXRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | – | Sell |
-23,723
| Closed | -$22.4K | – | 4812 |
|
|
2025
Q2 | $22.4K | Buy |
+23,723
| New | +$15.4K | ﹤0.01% | 4218 |
|
|
2024
Q1 | – | Sell |
-359,210
| Closed | -$550K | – | 4601 |
|
|
2023
Q4 | $550K | Sell |
359,210
-424,912
| -54% | -$505K | ﹤0.01% | 3469 |
|
|
2023
Q3 | $855K | Sell |
784,122
-429,604
| -35% | -$754K | ﹤0.01% | 3152 |
|
|
2023
Q2 | $2.78M | Sell |
1,213,726
-1,727,271
| -59% | -$4.59M | ﹤0.01% | 2358 |
|
|
2023
Q1 | $7.15M | Sell |
2,940,997
-136,976
| -4% | -$314K | 0.01% | 1645 |
|
|
2022
Q4 | $5.88M | Buy |
3,077,973
+33,996
| +1% | +$72.3K | 0.01% | 1942 |
|
|
2022
Q3 | $7.31M | Sell |
3,043,977
-184,095
| -6% | -$510K | 0.01% | 1672 |
|
|
2022
Q2 | $6M | Sell |
3,228,072
-632
| -0% | -$1.21K | 0.01% | 1914 |
|
|
2022
Q1 | $6.75M | Buy |
3,228,704
+420,276
| +15% | +$1.16M | 0.01% | 1987 |
|
|
2021
Q4 | $11.1M | Sell |
2,808,428
-407,620
| -13% | -$1.98M | 0.01% | 1580 |
|
|
2021
Q3 | $15.5M | Sell |
3,216,048
-186,377
| -5% | -$765K | 0.02% | 1188 |
|
|
2021
Q2 | $15.6M | Buy |
3,402,425
+395,813
| +13% | +$1.91M | 0.02% | 1161 |
|
|
2021
Q1 | $17.6M | Buy |
3,006,612
+1,212,603
| +68% | +$8.4M | 0.02% | 999 |
|
|
2020
Q4 | $6.14M | Buy |
1,794,009
+827,402
| +86% | +$1.58M | 0.01% | 1714 |
|
|
2020
Q3 | $1.39M | Sell |
966,607
-352,544
| -27% | -$628K | ﹤0.01% | 2638 |
|
|
2020
Q2 | $2.63M | Buy |
1,319,151
+806,739
| +157% | +$1.58M | ﹤0.01% | 2178 |
|
|
2020
Q1 | $999K | Buy |
512,412
+349,441
| +214% | +$1.04M | ﹤0.01% | 2730 |
|
|
2019
Q4 | $676K | Buy |
162,971
+147,109
| +927% | +$566K | ﹤0.01% | 3238 |
|
|
2019
Q3 | $48K | Sell |
15,862
-49,575
| -76% | -$153K | ﹤0.01% | 3728 |
|
|
2019
Q2 | $411K | Sell |
65,437
-170,684
| -72% | -$1.02M | ﹤0.01% | 3166 |
|
|
2019
Q1 | $1.31M | Sell |
236,121
-32,355
| -12% | -$197K | ﹤0.01% | 2436 |
|
|
2018
Q4 | $1.78M | Buy |
268,476
+173,096
| +181% | +$1.4M | ﹤0.01% | 2252 |
|
|
2018
Q3 | $1.02M | Buy |
95,380
+17,744
| +23% | +$203K | ﹤0.01% | 2694 |
|
|
2018
Q2 | $932K | Buy |
77,636
+31,741
| +69% | +$325K | ﹤0.01% | 2739 |
|
|
2018
Q1 | $393K | Buy |
45,895
+11,017
| +32% | +$102K | ﹤0.01% | 3009 |
|
|
2017
Q4 | $345K | Buy |
34,878
+3,257
| +10% | +$33.8K | ﹤0.01% | 3175 |
|
|
2017
Q3 | $389K | Sell |
31,621
-83,635
| -73% | -$1.24M | ﹤0.01% | 3035 |
|
|
2017
Q2 | $1.9M | Sell |
115,256
-53,238
| -32% | -$824K | ﹤0.01% | 2011 |
|
|
2017
Q1 | $2.42M | Buy |
168,494
+80,542
| +92% | +$1.19M | 0.01% | 1723 |
|
|
2016
Q4 | $1.22M | Sell |
87,952
-579,178
| -87% | -$9.29M | ﹤0.01% | 2343 |
|
|
2016
Q3 | $12.1M | Buy |
667,130
+469,827
| +238% | +$7.56M | 0.03% | 792 |
|
|
2016
Q2 | $2.83M | Buy |
197,303
+113,003
| +134% | +$1.53M | 0.01% | 1679 |
|
|
2016
Q1 | $1.01M | Buy |
84,300
+64,991
| +337% | +$681K | ﹤0.01% | 2348 |
|
|
2015
Q4 | $257K | Sell |
19,309
-2,891
| -13% | -$35.5K | ﹤0.01% | 3454 |
|
|
2015
Q3 | $238K | Buy |
+22,200
| New | +$242K | ﹤0.01% | 3431 |
|
|
2015
Q2 | – | Sell |
-1,685
| Closed | -$11K | – | 3825 |
|
|
2015
Q1 | $11K | Buy |
+1,685
| New | +$11.5K | ﹤0.01% | 3574 |
|
|
2014
Q2 | – | Sell |
-5,472
| Closed | -$66K | – | 4421 |
|
|
2014
Q1 | $66K | Sell |
5,472
-39,926
| -88% | -$510K | ﹤0.01% | 4193 |
|
|
2013
Q4 | $572K | Buy |
45,398
+7,139
| +19% | +$114K | ﹤0.01% | 3632 |
|
|
2013
Q3 | $635K | Buy |
38,259
+20,881
| +120% | +$350K | ﹤0.01% | 3401 |
|
|
2013
Q2 | $264K | Buy |
+17,378
| New | +$264K | ﹤0.01% | 3638 |
|
Other funds holding LXRX
AG
SL
SC
